Filter News
Area of Research
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (2)
- (-) Machine Learning (1)
- (-) Physics (2)
- (-) Security (2)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (1)
- Bioenergy (6)
- Clean Water (1)
- Composites (2)
- Computer Science (4)
- Cybersecurity (2)
- Environment (4)
- Isotopes (1)
- Materials Science (2)
- Neutron Science (8)
- Nuclear Energy (2)
- Quantum Science (1)
- Summit (1)
- Sustainable Energy (5)
- Transportation (2)
Media Contacts
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
An ORNL-led team's observation of certain crystalline ice phases challenges accepted theories about super-cooled water and non-crystalline ice. Their findings, reported in the journal Nature, will also lead to better understanding of ice and its various phases found on other planets, moons and elsewhere in space.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
A team of scientists has for the first time measured the elusive weak interaction between protons and neutrons in the nucleus of an atom. They had chosen the simplest nucleus consisting of one neutron and one proton for the study.
Brixon, Inc., has exclusively licensed a multiparameter sensor technology from the Department of Energy’s Oak Ridge National Laboratory. The integrated platform uses various sensors that measure physical and environmental parameters and respond to standard security applications.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.